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Edited by Veli-Pekka LehtoAbstract Phosphorylation of the Ca2+ and membrane-binding
protein annexin 1 by epidermal growth factor (EGF) receptor tyr-
osine kinase has been thought to be involved in regulation of the
EGF receptor traﬃcking. To elucidate the interaction of annexin
1 during EGF receptor internalization, we followed the distribu-
tion of annexin 1-GFP fusion proteins at sites of internalizing
EGF receptors. The observed association of annexin 1 with
EGF receptors was conﬁrmed by immunoprecipitation. We found
that this interaction was independent of a functional phosphoryla-
tion site in the annexin 1 N-terminal domain but mediated
through the Ca2+ binding core domain.
 2004 Published by Elsevier B.V. on behalf of the Federation of
European Biochemical Societies.
Keywords: Annexin 1; Epidermal growth factor receptor;
Endocytosis; Receptor clustering1. Introduction
Annexin 1 is a member of the Ca2+ and phospholipid-bind-
ing annexin protein family of cytosolic proteins, which can
reversibly and Ca2+-dependently associate with cellular mem-
branes. Its highly conserved protein core domain harbors the
Ca2+- and phospholipid-binding sites, whereas the N-terminal
domain is variable and unique and is thought to regulate spe-
ciﬁc biological actions of annexin 1. Several annexins have
been implicated in vesicular traﬃcking and membrane fusion
events, and at least in some cases the Ca2+-dependent mem-
brane association of the proteins appears to be of critical
importance for this role (for review, see [1]). Annexin 1 has
been found to associate with the plasma membrane and endo-
somal membranes [2–6], and it has been shown that the integ-
rity of the Ca2+-binding sites is essential for the binding of
annexin 1 to endosomal membranes [4,6]. The N-terminal do-
main of annexin 1 contains phosphorylation sites for proteinAbbreviations: EGF, epidermal growth factor; EGFR, EGF receptor
*Corresponding authors. Fax: +49 251 8356748.
E-mail addresses: gerke@uni-muenster.de (V. Gerke),
rescher@uni-muenster.de (U. Rescher).
0014-5793/$22.00  2004 Published by Elsevier B.V. on behalf of the Feder
doi:10.1016/j.febslet.2004.10.078kinase C and several tyrosine kinases including the epidermal
growth factor (EGF) receptor tyrosine kinase, which phos-
phorylates tyrosine 21 [7–10]. Phosphorylation of the protein,
which is induced by growth factors and cytokines, including
EGF, insulin, HGF, growth hormone, and angiotensin II
[2,11–14], is reported to participate in mediating or regulating
the mitogenic response [15,16]. Annexin 1 is highly expressed
and phosphorylated during hepatocarcinoma development
and has been implicated in liver regeneration and tumorigen-
esis, probably by modulating EGF receptor (EGFR) activity
[17]. A link between annexin 1 and EGFR signaling has also
been observed in lung cells [18]. In particular, phosphorylation
of annexin 1 by activated EGFR has been proposed to play a
role in mediating inward vesiculation in multivesicular endo-
somes and thereby the sorting of internalized EGFR to the
degradative lysosomal pathway [2]. Although a function of
annexin 1 in regulating endosomal EGFR traﬃcking has long
been postulated, an association of annexin 1 with EGFR dur-
ing the course of receptor endocytosis has not been investi-
gated so far. To analyze such spatial and temporal relation
between EGFR and annexin 1, we therefore monitored the
subcellular distribution of annexin 1 or annexin 1 mutant pro-
teins labeled with green ﬂuorescent protein (GFP) to sites of
internalizing EGF receptors in single living cells. We show that
antibody- clustered EGFR co-localizes with annexin 1 at the
plasma membrane and at vesicular structures during internal-
ization. This association, which can be veriﬁed by co-immuno-
precipitation, requires the Ca2+-binding annexin 1 core
domain.2. Materials and methods
2.1. Cell culture and transfection
The modiﬁed HeLa cell line HeLa dynK44A expressing a non-func-
tional dynamin mutant under tetracycline control [19] was kindly do-
nated by Dr. S. Schmid (The Scripps Research Institute, La Jolla,
USA). Cells were maintained in Dulbeccos modiﬁed Eagles medium
(Invitrogen, Karlsruhe, Germany) supplemented with 5% fetal calf ser-
um, glutamine and 1 lg/ml tetracycline (Sigma–Aldrich, Taufkirchen,
Germany) in a 5% CO2 incubator at 37 C. The overexpression of the
non-functional, dominant-negative dynamin was induced by tetracy-
cline deprivation for at least 48 h. For transient transfection, the cal-
cium phosphate method was used. Prior to transfection, the cell
culture medium was replaced with fresh medium. 1–3 lg DNA was di-
luted in 150 ml HEPES buﬀer (HBS: 20 mM HEPES, pH 7.0, 140 mMation of European Biochemical Societies.
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with 10 ll of a 2 M CaCl2 solution. The mixture was incubated at room
temperature for 30 min and added to the culture medium of one well of
a 6-well plate. Cells were used for experiments 24 h after transfection.
2.2. Antibodies and immunoblotting
The rabbit polyclonal anti-annexin 1 antibody r656 was described
previously [4]. Rabbit polyclonal anti-EGFR antibody 1005, mouse
monoclonal antibody 528 recognizing a cell surface epitope of human
EGFR, and mouse monoclonal anti-GFP antibody were purchased
from Santa Cruz Biotechnology Inc. (California, USA). Total cell
lysates or immunoprecipitated proteins were resolved by 10% SDS–
PAGE and electrophoretically transferred to nitrocellulose. The mem-
brane was blocked with 5% non-fat milk powder in TBS-T (50 mM
Tris, pH 7.5, 150 mMNaCl, and 0.5% Tween 20) prior to probing with
the primary antibody for 1 h at room temperature and then with the
HRP-coupled appropriate secondary antibodies (Amersham Pharma-
cia Biotec, Freiburg, Germany). Bands were visualized by ECL (Amer-
sham Pharmacia Biotec, Freiburg, Germany).
2.3. Annexin 1 expression constructs
The expression constructs anx1-GFP, cmanx1-GFP, and anx1core-
GFP were described previously [1]. To generate the plasmids encoding
anx1Y21A-GFP and anx1Y21E-GFP with a mutated EGFR phos-
phorylation site Y21, a fragment encoding amino acids 1–27 of the
annexin 1 N-terminal domain was excised from wild-type anx1-GFP
and then replaced with synthetic double-stranded oligonucleotides
installing the amino acid exchanges Y21A or Y21E. Constructs were
conﬁrmed by sequencing (SEQLAB, Go¨ttingen, Germany).
2.4. Preparation of cell lysates and immunoprecipitation
The cell monolayers were rinsed with ice-cold PBS and then lysed for
30 min with RIPA buﬀer (50 mM Tris–HCl, pH 7.5, 150 mM NaCl, 2
mM EDTA, 2 mM EGTA, 0.5% DOC, and 1% NP-40) containing a
cocktail of protease and phosphatase inhibitors (10 lg/ml leupeptin,
10 lg/ml E64, 10 lg/ml pepstatin, 10 lg/ml aprotinin, and 40 ll/ml tryp-
sin inhibitor, 4 mM AEBSF, 10 lM benzamidin and MG-101, 50 mM
NaF, 10 lMNaVO3, 2 mM sodium pyrophosphate and 10 mM b-glyc-
erophosphate). Lysates were centrifuged for 20 min at 20 000 · g. Sup-
ernatants were incubated at 4 Cwith 4 lg primary antibody for at least
2 h and subsequently incubated for two hours with protein A–Seph-
arose (Amersham Pharmacia Biotec, Freiburg, Germany). Beads were
spun down, washed three times with RIPA buﬀer and the adsorbed pro-
teins were subjected to immunoblotting analysis.
2.5. In vivo labeling of EGF receptor and EGFR clustering
Transfected cells grown on coverslips were serum-starved overnight.
For EGF receptor labeling with ﬂuorescent EGF, cells were exposed to
EGF complexed to Texas Red (Texas Red EGFcomplex, Molecular
Probes, Leiden, The Netherlands) at a ﬁnal concentration of 2 lg/ml in
serum-free medium containing 1% BSA at 37 C. For EGFR cluster-
ing, cells were incubated with anti EGFR antibody 528 directed
against a cell surface epitope of human EGFR (diluted 1:100 in ser-
um-free Dulbeccos modiﬁed Eagles medium containing 1% BSA)
for 15 min at 37 C. Subsequently, cells were rinsed with PBS and clus-
tering of EGFR was obtained by subsequent incubation with Texas
Red-labeled secondary antibodies (15 lg/ml) for 15 min at 37 C.
The cells were then rinsed with ice-cold PBS and ﬁxed with 4% PFA
for 15 min at room temperature. In control cells, ﬁxation was carried
out after incubation with the primary antibody, i.e., prior to receptor
clustering. Coverslips were mounted in Mowiol containing 4% n-pro-
pyl gallate as antifade agent and analyzed using a confocal laser scan-
ning microscope (Zeiss LSM 510 Meta).3. Results and discussion
3.1. Annexin 1 co-localizes with internalizing EGFR
In order to analyze the spatial and temporal association of
annexin 1 with EGFR, we employed HeLa cells ectopically
expressing annexin 1-GFP, which was shown previously to
localize to the same structures as endogenous annexin 1 [6].Consistent with previous observations, the annexin 1-GFP sig-
nal was present on vesicular structures dispersed throughout the
cell which had been identiﬁed earlier as transferrin receptor-
positive endosomes [6]. Upon incubation of annexin 1-GFP
expressing cells with ﬂuorescent Texas Red EGF complex
for 5 min at 37 C, co-localization of internalized EGF with
annexin 1 could be observed (Fig. 1A, upper panel). To analyze
whether annexin 1 also associates with EGF-bound EGFR at
the plasma membrane or only localizes to intracellular vesicles
containing internalized receptor, we used HeLa cells stably
transfected with dynK44A, which are conditionally defective
for receptor-mediated endocytosis. In this cell line overexpress-
ing a dominant-negative GTPase-deﬁcient mutant dynamin
(dynK44A), endocytosis of ligands such as transferrin and
EGF is eﬀectively blocked, probably by inhibiting the ﬁssion
of clathrin-coated vesicles from the plasma membrane [19–
21]. As shown in Fig. 1A, we observed a marked reduction of
intracellular vesicles containing annexin 1 and internalized
EGF in the dynK44A overexpressing cells. Rather enhanced ann-
exin 1-GFP and Texas Red signals are observed at the plasma
membrane of the dynK44A overexpressing cells (Fig. 1A, lower
panel).
To further enhance the EGFR label at the plasma mem-
brane, we next used anti-EGFR antibodies to induce receptor
oligomerization and selectively cluster the plasma membrane
resident receptor into larger structures which are easily identi-
ﬁed by microscopy. Serum-starved cells were incubated for 15
min with an antibody directed against the external domain of
the EGFR that competes with EGF for the EGF-binding site
and causes receptor dimerization [22]. The cells were then di-
rectly, without ﬁxation or any other treatment, incubated with
a secondary antibody linked to a red ﬂuorescent dye. Thereaf-
ter, the cells were ﬁxed with PFA. In controls, cells were ﬁxed
between the antibody incubations to prevent clustering. In
these control cells, EGFR was diﬀusely distributed over the
plasma membrane. In contrast, the antibody cross-linking in
live cells led to the formation of EGFR clusters (Fig. 1B).
Interestingly, these clusters co-localized with the annexin 1-
GFP-positive vesicles. As seen in the xz sections, some of the
clusters were internalized into the cell. However, co-localiza-
tion of the EGFR clusters was not observed with annexin 3-
or annexin 6-GFP (not shown).
Next, we examined whether plasma membrane attachment
of vesicles containing EGFR clusters is a prerequisite for ann-
exin 1 recruitment. Therefore, we performed in vivo crosslink-
ing of EGFR in HeLa cells induced to express dynK44A. As
shown in Fig. 1B, induction of dynK44A expression by tetracy-
cline deprivation results in an accumulation of EGFR clusters
at the plasma membrane. Likewise, we also observed a shift of
the annexin 1-GFP signal which was concentrated beneath the
plasma membrane.
3.2. Association with EGFR is mediated by the annexin 1 core
domain
The annexin 1 N-terminal domain harbors a phosphoryla-
tion site (Tyr21) for EGFR tyrosine kinase activity. Phos-
phorylation of the protein through the internalized receptor
has been proposed to regulate inward vesiculation in late endo-
somal compartments during receptor internalization [2]. To
analyze the contribution of this phosphorylation to the recruit-
ment of annexin 1 to sites of EGFR clusters, we generated ann-
exin 1 mutants in which Tyr21 had been replaced by Ala
Fig. 2. EGFR was in vivo crosslinked in cells transiently expressing
annexin 1-GFP fusion proteins as indicated. Annexin 1 mutants with
Tyr21 replaced by Ala (anx1 Y21A-GFP) to prevent phosphorylation
by activated EGFR or by Glu (anx1 Y21E-GFP) to mimic a
phosphorylated tyrosine residue, or the N-terminally truncated ann-
exin 1-GFP fusion protein lacking the ﬁrst 40 amino acid residues
(anx1core) localized to EGFR clusters. Cells expressing cmanx1-GFP
(all three type II high aﬃnity Ca2+-binding sites inactivated) show a
diﬀuse cytosolic GFP staining and no co-localization of the GFP label
with EGFR clusters was observed. Bars, 10 lm.
Fig. 1. Co-localization of annexin 1-GFP with EGFR. Non-induced
HeLa cells (dynwt) or cells induced to express dominant-negative
GTPase-deﬁcient dynaminK44A (dynK44A) were transiently transfected
with GFP-tagged annexin 1. (A) Cells were exposed for 5 min to Texas
Red EGF. In the absence of dynK44A (upper panels), ﬂuorescent EGF
was taken up into intracellular vesicles positive for annexin 1-GFP,
whereas in cells expressing dynK44A (lower panels), both the EGF and
the annexin 1-GFP signals accumulated at the cell periphery. Note that
for obtaining higher signal intensities to better visualize the EGF and
annexin 1-GFP distributions, the images were obtained by epiﬂuores-
cence microscopy. (B) In vivo antibody labeling of EGFR was either
followed by cross-linking of EGFR–antibody complexes with second-
ary antibodies (clustered) or by ﬁxation and subsequent staining with
secondary antibodies. Confocal x-y analysis of the EGFR distribution
shows that after crosslinking of EGFR, the receptor accumulated in
clusters at the plasma membrane whereas in cells treated with anti-
EGFR antibodies followed by immediate ﬁxation, EGFR was diﬀusely
distributed. Confocal x-z sections reveal that in wild-type cells,
clustered receptors appear to be internalized whereas in dynK44A
expressing cells they remain at the plasma membrane. Bar, 10 lm.
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EGFR or by Glu (anx1Y21E-GFP) to mimic a phosphoryl-
ated tyrosine residue. Interestingly, in each case, co-localiza-
tion of the GFP fusion proteins with EGFR clusters was
detected (Fig. 2), ruling out the possibility that phosphoryla-
tion at Tyr21 leads to a major change in the localization of
annexin 1 at vesicles containing internalized receptor clusters.
Association of annexin 1 with endosomes has been shown to
be dependent on the integrity of the Ca2+-binding sites in the
core domain [6]. To elucidate whether the annexin 1 associa-
tion with the EGFR clusters is also dependent on the Ca2+-
binding sites found in the annexin core module, we ﬁrst carried
out the EGFR clustering in cells expressing an N-terminally
truncated annexin 1-GFP fusion protein which lacks the ﬁrst
40 amino acid residues (anx1core). Again, association of this
mutant with plasma membrane-resident and internalized
EGFR clusters could be observed (Fig. 2). We next expressed
the mutant cmanx1-GFP in which all three high aﬃnity Ca2+-binding sites, the so-called type II sites, were inactivated. Cells
expressing this mutant show a diﬀuse cytosolic GFP staining
as observed previously [1], and no co-localization of the
GFP label with EGFR clusters or intracellular vesicular struc-
tures (Fig. 2). Taken together, these results indicate that the
Ca2+-dependent membrane binding mediated through the ann-
exin 1 core is required for association of annexin 1 with the
EGFR clusters. However, we cannot rule out the possibility
that there are subtle diﬀerences in the endosomal populations
to which the diﬀerent annexin 1 mutants are directed.
To conﬁrm the association of annexin 1 with the EGFR re-
vealed by confocal ﬂuorescence imaging of the annexin 1-GFP
expressing cells, we carried out co-immunoprecipitation experi-
ments using total cell lysates from HeLa cells transfected with
the annexin 1-GFP expression plasmids. Equal amounts of pro-
teins from the lysates were subjected to immunoprecipitation
with antibodies against EGFR. In parallel, the presence of the
annexin 1-GFP fusion proteins in the lysates was veriﬁed by ana-
lyzing samples of the lysates by Western blotting using anti-
annexin 1 antibodies or anti-GFP antibodies. As shown in
Fig. 3A, all chimeric proteins were expressed at a comparable
level. Consistent with the results obtained by direct ﬂuorescence
microscopy, all of the diﬀerent annexin 1 derivatives co-localiz-
ing with EGFR clusters, i.e., wt, truncated or tyrosine 21
mutants, were co-precipitated with the EGFR, whereas
cmanx1-GFP was not detected in the immunoprecipitates
(Fig. 3B). Hence, the site in annexin 1 required for association
with EGFR is not localized in the N-terminal domain and phos-
phorylation of tyrosine-21 is not required for EGFR/annexin 1
interactions.
3.3. Conclusions
By in vivo labeling of EGFR on the cell surface of HeLa
cells expressing annexin 1-GFP fusion proteins, we could show
that annexin 1 co-localizes with the cross-linked receptor. The
Fig. 3. Co-immunoprecipitation of EGFR with annexin 1-GFP
derivatives. (A) Cell lysates from HeLa cells transfected with the
indicated annexin 1-GFP plasmids or the empty vector as control were
analyzed for expression of the respective fusion protein by SDS–PAGE
and immunoblotting with anti-GFP antibody. (B) Subsequently, the
lysates were subjected to immunoprecipitation (IP) with anti-EGFR
antibody and the precipitated proteins were probed by immunoblot-
ting (WB) with either anti-EGFR or anti-GFP antibody.
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structures already occurs at the plasma membrane, since it
could be observed in cells where dynamin-dependent endocy-
tosis is blocked. It is speciﬁc for annexin 1 and could not be
observed with other annexins like annexin 3 and annexin 6.
Mutations in the N-terminal Tyr21, the phosphorylation site
for EGFR kinase activity, do not abrogate the co-localization
of this mutant protein with the internalized receptor. Further-
more, the association is mediated by the core domain of ann-
exin 1 and seems to depend on the integrity of the Ca2+-
binding sites of the protein.
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